Aminazin (chlorpromazine) coated tablets 0.1g. №10

Description

Ingredients:

active substance: chlorpromazine;

1 tablet contains chlorpromazine hydrochloride 50 mg or 100 mg;

excipients: celactose (a mixture of lactose monohydrate and powdered cellulose (75:25)), colloidal anhydrous silicon dioxide, aluminum hydroxide, calcium stearate, stearic acid, talc, hypromellose, titanium dioxide (E 171), yellow sunset FCF (E 110) .

Indications:

In psychiatry – chronic paranoid and/or hallucinatory states, including in patients with schizophrenia (hallucinatory-delusional, hebephrenic, catatonic syndromes); manic excitement in manic-depressive psychosis; agitated depression (with presenile and manic-depressive psychosis).

In neurology — increased muscle tone, torpid pain syndrome (in combination with analgesics).

Prolonged hiccups (for the treatment of adults).

Contraindications:

Hypersensitivity to any components of the drug. Severe disorders of liver function (cirrhosis, hepatitis, hemolytic jaundice) and/or kidneys (nephritis, acute pyelitis, renal amyloidosis); disorders of hematopoietic organs; progressive systemic diseases of the brain and spinal cord (slow neuroinfections, multiple sclerosis); myxedema; severe cardiovascular diseases (decompensated heart failure and heart defects, severe myocardial dystrophy and arterial hypotension, rheumatic carditis in late stages); thromboembolism; late stage of bronchiectasis; closed-angle glaucoma; urinary retention caused by prostatic hyperplasia; pronounced suppression of the central nervous system; stroke; acute period of craniocerebral injury; gallstone and urolithiasis; stomach and duodenal ulcer in the period of exacerbation or in the anamnesis; acute infectious diseases; hypothyroidism, pheochromocytoma, myasthenia gravis, history of agranulocytosis, breastfeeding period, comatose state, brain injuries; simultaneous use with barbiturates, alcohol, drugs, dopaminergic antiparkinsonian agents, citalopram, escitalopram.

Directions:

Assign to adults and children over 12 years old orally after meals. Doses, frequency of administration and treatment regimens with Aminazin (chlorpromazine) coated tablets are set by the doctor individually, depending on the indications and the patient’s condition. Doses should be selected by increasing, starting with the minimum. The duration of treatment is from 3 weeks to 2–4 months or more (patients with a chronic course of the disease should be prescribed long-term maintenance therapy).

In the treatment of mental illnesses in adults and children over 12 years of age, the initial dose is 50–100 mg per day, divided into 1–2 doses. Further, the dose can be gradually increased (taking into account tolerability) by 50 mg every 3–4 days to 300–600 mg per day, dividing it into 3–4 doses. The course of treatment — from 3 weeks to 2–4 months.

In some cases, the daily dose of the drug can be increased to 700 mg–1 g (especially for patients with a chronic course of the disease and psychomotor agitation). In this case, the daily dose should be divided into 4 doses (morning, afternoon, evening and night). The duration of treatment with large doses of Aminazin (chlorpromazine) coated tablets should not exceed 1-1.5 months, if the effect is insufficient, it is advisable to switch to treatment with other drugs.

Maximum doses: single — 300 mg, daily — 1.5 g.

In weakened patients, elderly patients, with diseases of the liver and cardiovascular system, the dose should be reduced by 2-3 times (but not more than 300 mg per day).

Prolonged hiccups. Prescribe in a dose of 50 mg 3-4 times a day.